From startups to legacy brands, you're making your mark. We're here to help.
Key Links
Prepare for future growth with customized loan services, succession planning and capital for business equipment.
Key Links
Serving the world's largest corporate clients and institutional investors, we support the entire investment cycle with market-leading research, analytics, execution and investor services.
Key Links
Providing investment banking solutions, including mergers and acquisitions, capital raising and risk management, for a broad range of corporations, institutions and governments.
Your partner for commerce, receivables, cross-currency, working capital, blockchain, liquidity and more.
Key Links
A uniquely elevated private banking experience shaped around you.
Whether you want to invest on your own or work with an advisor to design a personalized investment strategy, we have opportunities for every investor.
For Companies and Institutions
From startups to legacy brands, you're making your mark. We're here to help.
Serving the world's largest corporate clients and institutional investors, we support the entire investment cycle with market-leading research, analytics, execution and investor services.
Your partner for commerce, receivables, cross-currency, working capital, blockchain, liquidity and more.
Prepare for future growth with customized loan services, succession planning and capital for business equipment.
Providing investment banking solutions, including mergers and acquisitions, capital raising and risk management, for a broad range of corporations, institutions and governments.
For Individuals
A uniquely elevated private banking experience shaped around you.
Whether you want to invest on you own or work with an advisor to design a personalized investment strategy, we have opportunities for every investor.
Explore a variety of insights.
Key Links
Insights by Topic
Explore a variety of insights organized by different topics.
Key Links
Insights by Type
Explore a variety of insights organized by different types of content and media.
Key Links
We aim to be the most respected financial services firm in the world, serving corporations and individuals in more than 100 countries.
Key Links
Biopharma and medtech venture investment continued its strong momentum into 2025, with larger deal sizes despite fewer rounds. Biopharma venture investment held steady with $6.7 billion invested across 109 rounds, while medtech saw $3.7 billion deployed through 117 funding rounds.
The licensing landscape showed significant shifts in Q1 2025, with biopharma licensing deals reaching $56.8 billion in total announced value, marked by higher upfront payments for later-stage programs. The medtech sector saw 286 licensing partnerships disclosed with $3.7 billion in total value, including $871 million in upfront payments.
M&A activity showed divergent patterns across sectors in early 2025, with biopharma seeing 27 transactions totaling $25.2 billion, including one large deal surpassing $14 billion. Meanwhile, medtech M&A activity tempered slightly with 57 acquisitions in Q1 totaling $9.2 billion, but still maintained multiyear-high transaction numbers.
IPO markets remained cautious in both sectors to kick off the new year. Biopharma saw four IPOs on Nasdaq raising $770 million, while medtech completed just two public offerings totaling $467 million. This reflects the continued trend of companies staying private longer to raise larger private rounds.
J.P. Morgan’s biopharma therapeutics and medtech licensing reports explore the movement in each sector, offering insight into industry and investment trends that defined the first quarter of 2025. The reports, powered by DealForma, highlight:
Download these reports to gain deeper insights into current dealmaking trends, and connect with our Startup Banking experts to learn more.
Kathryn McDonough
Head of Life Sciences, Innovation Economy, J.P. Morgan Commercial Banking
Skip Kelly
Head of Healthcare VC Coverage, Innovation Economy, J.P. Morgan Commercial Banking
Outlook
April 2025 inflation rate lower than expected: What this means for investors
May 14, 2025
The April 2025 Consumer Price Index (CPI) print from the Bureau of Labor Statistics showed that inflation cooled further in April. However, the potential impact of tariffs still looms.
Outlook
May 2025 Fed Meeting: Rates hold firm again as FOMC takes ‘wait and see’ approach
May 08, 2025
The Federal Reserve held interest rates steady during its May meeting and vowed to take a “wait-and-see” approach to future cuts.
Outlook
What April’s solid jobs report means for the stock market and interest rates
May 05, 2025
The April 2025 jobs report underscored the labor market’s resilience in the face of trade policy uncertainties and recent market volatility.
Outlook
U.S. adds 228K jobs in March amidst market volatility: How investors should read the numbers
Apr 07, 2025
The March 2025 jobs report was stronger than expected, though the unemployment rate slightly ticked up. How might the Fed react and what does the data mean for investors?
Outlook
2025 Outlook update: How to parse policy uncertainty
Mar 24, 2025
From tariffs to technology, clashing forces are driving global markets.
Outlook
March 2025 Fed meeting: Interest rates kept steady, slower economic growth projected
Mar 20, 2025
Fed held rates steady for a second straight month and provided economic projections forecasting slower growth and higher inflation by year-end.
Outlook
Eye on the Market: Fifty days of grey
Mar 12, 2025
In this edition of Eye on the Market, Michael Cembalest gives his take on the Trump administration’s economic policies 50 days in, as well as their effect on markets thus far.
Outlook
Investment implications of President Trump’s first month in office
Mar 12, 2025
In his first 30 days, President Trump has made policy decisions on tariffs, immigration and deregulation. Here’s what investors need to know moving forward.
You're now leaving J.P. Morgan
J.P. Morgan’s website and/or mobile terms, privacy and security policies don’t apply to the site or app you're about to visit. Please review its terms, privacy and security policies to see how they apply to you. J.P. Morgan isn’t responsible for (and doesn’t provide) any products, services or content at this third-party site or app, except for products and services that explicitly carry the J.P. Morgan name.